Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | EYA2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of EYA2 mRNA | CTD | PMID:22079256 | 17alpha-ethynylestradiol | multiple interactions | ISO | Eya2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EYA2 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | increases expression | ISO | Eya2 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of EYA2 mRNA | CTD | PMID:17942748 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of EYA2 mRNA | CTD | PMID:26496021 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Eya2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EYA2 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of EYA2 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of EYA2 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Eya2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of EYA2 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | EYA2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of EYA2 mRNA | CTD | PMID:22298810 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Eya2 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of EYA2 mRNA | CTD | PMID:20188158 | 4,4'-sulfonyldiphenol | increases expression | ISO | Eya2 (Mus musculus) | 6480464 | bisphenol S results in increased expression of EYA2 mRNA | CTD | PMID:30951980 | 4,4'-sulfonyldiphenol | increases methylation | ISO | Eya2 (Mus musculus) | 6480464 | bisphenol S results in increased methylation of EYA2 exon | CTD | PMID:33297965 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of EYA2 mRNA | CTD | PMID:24780913 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of EYA2 mRNA | CTD | PMID:31881176 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of EYA2 mRNA | CTD | PMID:28959563 | acrylamide | decreases expression | ISO | EYA2 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of EYA2 mRNA | CTD | PMID:32763439 | aflatoxin B1 | decreases expression | ISO | EYA2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of EYA2 mRNA | CTD | PMID:22100608 | aflatoxin B1 | decreases methylation | ISO | EYA2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of EYA2 intron | CTD | PMID:30157460 | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of EYA2 mRNA | CTD | PMID:23630614 | all-trans-retinoic acid | increases expression | ISO | Eya2 (Mus musculus) | 6480464 | Tretinoin results in increased expression of EYA2 mRNA | CTD | PMID:16604517 | all-trans-retinoic acid | increases expression | ISO | EYA2 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of EYA2 mRNA | CTD | PMID:23830798 | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of EYA2 mRNA | CTD | PMID:35163327 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of EYA2 mRNA | CTD | PMID:16483693 | benzbromarone | decreases activity | ISO | EYA2 (Homo sapiens) | 6480464 | Benzbromarone results in decreased activity of EYA2 protein | CTD | PMID:22545090 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of EYA2 mRNA | CTD | PMID:21839799 | benzo[a]pyrene | decreases expression | ISO | EYA2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of EYA2 mRNA | CTD | PMID:32234424 | benzo[a]pyrene | affects methylation | ISO | EYA2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of EYA2 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene | decreases methylation | ISO | EYA2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of EYA2 promoter | CTD | PMID:27901495 | benzo[a]pyrene | multiple interactions | ISO | Eya2 (Mus musculus) | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of EYA2 mRNA] | CTD | PMID:22228805 | bis(2-chloroethyl) sulfide | decreases expression | ISO | Eya2 (Mus musculus) | 6480464 | Mustard Gas results in decreased expression of EYA2 mRNA | CTD | PMID:15674843 | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Eya2 (Mus musculus) | 6480464 | Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of EYA2 mRNA] | CTD | PMID:33484791 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of EYA2 mRNA | CTD | PMID:26496021 | bisphenol A | multiple interactions | ISO | EYA2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of EYA2 gene | CTD | PMID:31601247 | bisphenol A | decreases methylation | ISO | EYA2 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of EYA2 gene | CTD | PMID:31601247 | bisphenol A | increases expression | ISO | Eya2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of EYA2 mRNA | CTD | PMID:30951980 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of EYA2 mRNA | CTD | PMID:25181051 more ... | bisphenol F | increases expression | ISO | Eya2 (Mus musculus) | 6480464 | bisphenol F results in increased expression of EYA2 mRNA | CTD | PMID:30951980 | bisphenol F | multiple interactions | ISO | EYA2 (Homo sapiens) | 6480464 | [bisphenol F co-treated with Fulvestrant] results in decreased methylation of EYA2 gene | CTD | PMID:31601247 | cadmium atom | increases expression | ISO | EYA2 (Homo sapiens) | 6480464 | Cadmium results in increased expression of EYA2 mRNA | CTD | PMID:31082426 | cadmium atom | multiple interactions | ISO | EYA2 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EYA2 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | EYA2 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EYA2 mRNA | CTD | PMID:35301059 | carbamazepine | affects expression | ISO | EYA2 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of EYA2 mRNA | CTD | PMID:25979313 | CGP 52608 | multiple interactions | ISO | EYA2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to EYA2 gene] | CTD | PMID:28238834 | chlorpyrifos | decreases expression | ISO | Eya2 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of EYA2 mRNA | CTD | PMID:32715474 | chromium(6+) | decreases expression | ISO | EYA2 (Homo sapiens) | 6480464 | chromium hexavalent ion results in decreased expression of EYA2 mRNA | CTD | PMID:30690063 | cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of EYA2 mRNA | CTD | PMID:20187946 | crocidolite asbestos | decreases expression | ISO | Eya2 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of EYA2 mRNA | CTD | PMID:29279043 | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of EYA2 mRNA | CTD | PMID:26577399 | cyclosporin A | decreases expression | ISO | EYA2 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of EYA2 mRNA | CTD | PMID:20106945 | dorsomorphin | multiple interactions | ISO | EYA2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EYA2 mRNA | CTD | PMID:27188386 | elemental selenium | increases expression | ISO | EYA2 (Homo sapiens) | 6480464 | Selenium results in increased expression of EYA2 mRNA | CTD | PMID:19244175 | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of EYA2 mRNA | CTD | PMID:30307764 | flavonoids | decreases expression | EXP | | 6480464 | Flavonoids results in decreased expression of EYA2 mRNA | CTD | PMID:18035473 | fulvestrant | multiple interactions | ISO | EYA2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of EYA2 gene and [bisphenol F co-treated with Fulvestrant] results in decreased methylation of EYA2 gene | CTD | PMID:31601247 | genistein | decreases expression | ISO | Eya2 (Mus musculus) | 6480464 | Genistein results in decreased expression of EYA2 mRNA | CTD | PMID:32186404 | glycidol | decreases expression | EXP | | 6480464 | glycidol results in decreased expression of EYA2 mRNA | CTD | PMID:24915197 | glyphosate | affects methylation | EXP | | 6480464 | Glyphosate affects the methylation of EYA2 gene | CTD | PMID:35440735 | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of EYA2 gene | CTD | PMID:35440735 | methylmercury chloride | decreases expression | ISO | EYA2 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of EYA2 mRNA | CTD | PMID:28001369 | N-Nitrosopyrrolidine | decreases expression | ISO | EYA2 (Homo sapiens) | 6480464 | N-Nitrosopyrrolidine results in decreased expression of EYA2 mRNA | CTD | PMID:32234424 | nickel atom | decreases expression | ISO | EYA2 (Homo sapiens) | 6480464 | Nickel results in decreased expression of EYA2 mRNA | CTD | PMID:24768652 and PMID:25583101 | nickel sulfate | decreases expression | ISO | EYA2 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of EYA2 mRNA | CTD | PMID:22714537 | O-methyleugenol | decreases expression | ISO | EYA2 (Homo sapiens) | 6480464 | methyleugenol results in decreased expression of EYA2 mRNA | CTD | PMID:32234424 | paracetamol | decreases expression | ISO | EYA2 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of EYA2 mRNA | CTD | PMID:26690555 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of EYA2 mRNA | CTD | PMID:33387578 | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of EYA2 mRNA | CTD | PMID:35163327 | phenylephrine | multiple interactions | EXP | | 6480464 | EYA2 protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 protein] and EYA2 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA protein] | CTD | PMID:17327491 | phenylmercury acetate | decreases expression | ISO | EYA2 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of EYA2 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | EYA2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EYA2 mRNA | CTD | PMID:27188386 | potassium chromate | multiple interactions | ISO | EYA2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of EYA2 mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | ISO | EYA2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of EYA2 mRNA | CTD | PMID:22079256 and PMID:22714537 | resveratrol | multiple interactions | ISO | EYA2 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of EYA2 mRNA | CTD | PMID:23557933 | retinyl acetate | increases expression | ISO | Eya2 (Mus musculus) | 6480464 | retinol acetate results in increased expression of EYA2 mRNA | CTD | PMID:16772331 | SB 431542 | multiple interactions | ISO | EYA2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EYA2 mRNA | CTD | PMID:27188386 | selenium atom | increases expression | ISO | EYA2 (Homo sapiens) | 6480464 | Selenium results in increased expression of EYA2 mRNA | CTD | PMID:19244175 | sodium arsenite | decreases expression | ISO | EYA2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of EYA2 mRNA | CTD | PMID:22714537 | sodium arsenite | affects methylation | ISO | EYA2 (Homo sapiens) | 6480464 | sodium arsenite affects the methylation of EYA2 gene | CTD | PMID:28589171 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of EYA2 mRNA | CTD | PMID:19281266 | streptozocin | multiple interactions | ISO | Eya2 (Mus musculus) | 6480464 | [Streptozocin co-treated with Dietary Fats] results in decreased expression of EYA2 mRNA and Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of EYA2 mRNA] | CTD | PMID:33484791 | titanium dioxide | increases expression | ISO | Eya2 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of EYA2 mRNA | CTD | PMID:27760801 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of EYA2 mRNA | CTD | PMID:33387578 | trichostatin A | increases expression | ISO | EYA2 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of EYA2 mRNA | CTD | PMID:24935251 | trimellitic anhydride | decreases expression | ISO | Eya2 (Mus musculus) | 6480464 | trimellitic anhydride results in decreased expression of EYA2 mRNA | CTD | PMID:19042947 | valproic acid | increases expression | ISO | EYA2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of EYA2 mRNA | CTD | PMID:23179753 and PMID:24383497 | valproic acid | affects expression | ISO | EYA2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of EYA2 mRNA | CTD | PMID:25979313 | vinclozolin | decreases methylation | EXP | | 6480464 | vinclozolin results in decreased methylation of EYA2 gene | CTD | PMID:31682807 | vitamin E | increases expression | ISO | EYA2 (Homo sapiens) | 6480464 | Vitamin E results in increased expression of EYA2 mRNA | CTD | PMID:19244175 | |